athenahealth Announces Acquisition of RazorInsights

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
athenahealth Announces Acquisition of RazorInsights

Transaction Cements athenahealth's Entrance Into the Inpatient Hospital Market and Advances Company Progress to Connect the Care Continuum

Complementary Track Records in Cloud Innovation, Client Satisfaction, and Delivery of Clinical and Financial Results Combine to Rival Legacy Health Information Systems and EHR Offerings

WATERTOWN, Mass., Jan. 14, 2015 (GLOBE NEWSWIRE) -- athenahealth, Inc. (Nasdaq: ATHN ), a leading provider of cloud-based services and mobile applications for medical groups and health systems, today announced it will acquire RazorInsights, a leader in cloud-based electronic health record (EHR) and financial solutions for rural, critical access and community hospitals. By uniting the strengths and resources of athenahealth and RazorInsights, the combined organization is positioned to introduce new cloud-based services tied to the delivery of clinical and financial results for rural, critical access and community hospitals. In addition to positioning athenahealth to serve a new segment of the health care market, athenahealth expects this acquisition to accelerate its work to advance connectedness across the care continuum.

athenahealth plans to leverage RazorInsights' inpatient expertise and award-winning technology to extend its presence into the 50-bed-and-under inpatient care environment, which accounts for approximately one-third of the U.S. hospital market. This move builds upon athenahealth's established position in the ambulatory space, where it serves more than 59,000 health care providers and has achieved Best in KLAS recognition for its revenue cycle management, EHR, and patient engagement services [i] .

"Today's hospital market is woefully underserved when it comes to IT systems and IT partners that are accountable for reducing costs, increasing quality, and enabling a better patient experience," said Jonathan Bush, chairman and CEO, athenahealth. "With RazorInsights, athenahealth will immediately be injected into the inpatient care environment; this is a natural extension for our cloud-based services, will tremendously grow our network knowledge, and will accelerate our introduction of results-oriented, inpatient solutions that hospitals can confidently invest in and demand accountability from."

Like athenahealth, a company with a long-standing commitment to supporting the needs of independent physician medical groups, RazorInsights got its start serving a struggling corner of the health care industry – one with an acute need for affordable and scalable EHR options. Today, both companies offer cloud-based solutions as an alternative to on-premise software implementations, which require large upfront and ongoing expenditures to install and operate.

"In light of pressures to consolidate, and in some cases, even shut down operations, there is a large and growing market for technologies and services that enable hospitals to deliver higher levels of patient care, reduce costs, and more effectively manage care at the population level. By teaming with athenahealth, we can accelerate our common vision to help health care provider organizations of all sizes remain independent and thrive despite market challenges," said Reed Liggin, President of RazorInsights. "Since our inception, RazorInsights has focused on helping rural, critical access and community hospitals be as efficient as possible within an environment of increasing regulatory demands and workflow processes. We believe that with athenahealth, we can expand the benefits we deliver to our current customers, and together introduce a new class of services that will overcome both industry pressures and the shortcomings of traditional EHR offerings."

athenahealth expects the addition of RazorInsights to bring many advantages and synergies to complement and extend athenahealth's presence across the health care market, as well as speed the development of future solutions that can advance connectedness across all phases of the care continuum:

  • Strong Customer Base – RazorInsights has deployed its solutions across 25 leading health care provider organizations and has presence in 15 states.
  • Leadership in Meaningful Use Attestations – RazorInsights is among the first in the nation whose clients have achieved Stage 2 Meaningful Use--something less than 35 percent [ii] of hospitals could claim as of December 2014. RazorInsights also achieved 100 percent client attestation for Meaningful Use Stage 1.
  • Complementary and Award-Winning Cloud Model – RazorInsights' cloud-based, open platform will allow athenahealth to integrate and build innovations and workflow processes to serve its growing client base. RazorInsights' EHR has been recognized on the Medical Economics Top 50 EHR list, as CIO Review's "20 Most Promising IT Vendor Solutions," and with a Fierce Innovation Award from FierceHealthcare .
  • Increased Network Knowledge - By extending the reach of athenahealth's national cloud network to support new market segments, athenahealth expects to broaden its scope of network insights and domain knowledge, and thereby improve its ability to streamline operations and enhance care coordination for current and future clients, as well as enable health information to follow patients across all care settings.
  • Talented Team – RazorInsights brings a dedicated, talented team whose health care knowledge and expertise has established the company as a leader in the rural, critical access and community hospital market. Located in Kennesaw, Georgia, the RazorInsights team will make a natural and complementary addition to athenahealth's growing Atlanta office.

About RazorInsights

Based in metro Atlanta, RazorInsights, a Bluff Point Associates portfolio company, is a dynamic healthcare information technology company recognized as a top 20 Most Promising Healthcare Solution and a Top 50 EHR. In keeping with the principle of Occam's Razor, it has created a simplified HIS solution for rural, critical access and community hospitals. Introducing ONE — a single-database, cloud solution offering a simple user experience with cutting-edge clinical tools and industry-standardized data. Hospitals across America use ONE to improve their performance and bottom line, which keeps local communities healthier. For more information, visit http://www.razorinsights.com .

About Bluff Point Associates

Bluff Point Associates is a private equity firm based in Westport, Connecticut. Bluff Point actively invests in middle-market information services companies supporting the banking, trust, securities, retirement and wealth management sectors of the financial services industry, as well as the healthcare information services sector.

About athenahealth, Inc.

athenahealth is a leading provider of cloud-based services for electronic health records ( EHR ), revenue cycle management and medical billing , patient engagement , care coordination , and population health management, as well as Epocrates and other point-of-care mobile apps. We connect care and drive meaningful, measurable results for more than 59,000 health care providers in medical practices and health systems nationwide. For more information, please visit www.athenahealth.com .

Forward-Looking Statements

This press release contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the anticipated benefits of the integration of RazorInsights' solutions with those of athenahealth, the nature of the prospective markets for those offerings, our progress towards advancements in care connectedness, and statements regarding changes in the health care industry and our positioning to lead such changes. The forward-looking statements in this release do not constitute guarantees of future performance. These statements are neither promises nor guarantees, and are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. In particular, the risks and uncertainties include, among other things: our fluctuating operating results; our variable sales and implementation cycles, which may result in fluctuations in our quarterly results; risks associated with the acquisition and integration of companies and new technologies to achieve expected synergies, including those related to our ability to successfully integrate the services and offerings of RazorInsights and realize the expected benefits; risks associated with our expectations regarding our ability to maintain profitability; the impact of increased sales and marketing expenditures, including whether increased expansion in revenues is attained and impacts on margins and profitability; changes in tax rates or exposure to additional tax liabilities; the highly competitive industry in which we operate and the relative immaturity of the market for our service offerings; and the evolving and complex governmental and regulatory compliance environment in which we and our clients operate. Forward-looking statements may often be identified with words such as "we expect," "we anticipate," "upcoming," "aim," or similar indications of future expectations. These statements are neither promises nor guarantees, and are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances, or otherwise. For additional disclosure regarding these and other risks faced by us, please see the disclosures contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at www.athenahealth.com and on the SEC's website at www.sec.gov .

[i] "2013 Best in KLAS Awards: Software & Services," January, 2014.© 2014 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com

[ii] Low 2014 MU 2 Attestation Numbers Validate Need for Shortened Reporting Period in 2015. (2014, January 1). Retrieved January 1, 2014, from http://chimecentral.org/low-2014-mu-2-attesta...riod-2015/

Holly Spring athenahealth, Inc. (Media) 617-402-1631 Dana Quattrochi athenahealth, Inc. (Investors) 617-402-1329

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 69

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 573

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 343

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 158

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 587

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 437

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 131

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

WISeKey Enhances Digital ID Solutions Across Africa

Updated Category News Views 199

WISeKey Expands Its Digital Identity Footprint Across Africa WISeKey International Holding Ltd is making significant strides in transforming digital identity solutions not only within Seychelles but also expanding into several other African nations. As a prominent player in cybersecurity, blockchain, and IoT, WISeKey is set to revolutionize how national ID systems...

Continue Reading
How to Send Event Leads Directly into Your CRM

Updated Category Business Views 149

Trade shows and conferences generate some of the highest-intent leads a sales team will ever encounter. Yet many of those conversations never convert—not because the prospect lost interest, but because the follow-up arrived too late or the contact details were lost somewhere between a badge scanner and a spreadsheet. Research from event marketing surveys consistently...

Continue Reading
Dreame Technology's Innovative Smart Home Solutions at CES 2025

Updated Category News Views 474

Dreame Technology Showcases Innovative Solutions at CES 2025 Dreame Technology, a pioneer in smart home solutions, has made waves at CES 2025 with the introduction of its next-generation smart home ecosystem. This new system streamlines home management and enhances everyday living through intelligent appliances that are easy to use and highly efficient. Revolutionizing...

Continue Reading
Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 374

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Cocoa Prices Plummet, Boosting Chocolate Makers Before Holidays

Updated Category News Views 253

Cocoa Prices Reach New Lows Recently, cocoa futures dropped to their lowest point in nearly two years, which is quite timely as we approach the season for hot chocolate and festive gifting. This price decline acts as a unique advantage for chocolate manufacturers who are just starting to see some relief after facing escalating ingredient costs over the past year, coupled...

Continue Reading